Tilray Brands, Inc. Capital Units, Authorized
Tilray Brands, Inc. (TLRY) had Capital Units, Authorized of 0 shares as of 2018-12-31, per its 10-K filed 2019-03-25.
Discontinued › Notes › Equity
us-gaap:CapitalUnitsAuthorized · last filed 2019-03-25
- 2018-12-31: Capital Units, Authorized 0.00 shares.
- 2018-09-30: Capital Units, Authorized 0.00 shares.
- 2018-06-30: Capital Units, Authorized 0.00 shares.
- 2017-12-31: Capital Units, Authorized 1.00 shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2018-12-31 | 0.00 shares 10-K · filed 2019-03-25 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-14 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-29 |
| 2017-12-31 | 1.00 shares 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |